Literature DB >> 3131279

Mechanisms of multidrug resistance and implications for therapy.

T Tsuruo1.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3131279      PMCID： PMC5917488          DOI： 10.1111/j.1349-7006.1988.tb01588.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN： 0910-5050


× No keyword cloud information.
  76 in total

1.  Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response.

Authors:  D Kessel; V Botterill; I Wodinsky
Journal:  Cancer Res       Date:  1968-05       Impact factor: 12.701

Review 2.  Multidrug-resistance phenotype in Chinese hamster ovary cells.

Authors:  V Ling; N Kartner; T Sudo; L Siminovitch; J R Riordan
Journal:  Cancer Treat Rep       Date:  1983-10

3.  Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.

Authors:  T Tsuruo; H Iida; M Nojiri; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

4.  Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells.

Authors:  T Skovsgaard
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

5.  Mutants of Chinese hamster ovary (CHO) cells with altered colcemid-binding affinity.

Authors:  V Ling; J E Aubin; A Chase; F Sarangi
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

6.  Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines.

Authors:  J R Riordan; K Deuchars; N Kartner; N Alon; J Trent; V Ling
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

7.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

Authors:  M Inaba; H Kobayashi; Y Sakurai; R K Johnson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

8.  Dimethylsulfoxide, retinoic acid and 12-O-tetradecanoylphorbol-13-acetate induce a selective decrease in the phosphorylation of P150, a surface membrane phosphoprotein of HL60 cells resistant to adriamycin.

Authors:  W Marsh; M S Center
Journal:  Biochem Biophys Res Commun       Date:  1986-07-16       Impact factor: 3.575

9.  Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.

Authors:  D R Bell; J H Gerlach; N Kartner; R N Buick; V Ling
Journal:  J Clin Oncol       Date:  1985-03       Impact factor: 44.544

10.  Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.

Authors:  D W Shen; A Fojo; J E Chin; I B Roninson; N Richert; I Pastan; M M Gottesman
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728
View more
  44 in total

1.  Multidrug resistance P-glycoprotein function of bone marrow hematopoietic cells and the reversal agent effect.

Authors:  Z Chen; A Takeshita; P Zou; Z Liu; M Kozaka; Y You; S Song; K Ohnishi; R Ohno
Journal:  J Tongji Med Univ       Date:  1999

2.  Purification and characterization of NF-R1 that regulates the expression of the human multidrug resistance (MDR1) gene.

Authors:  M Ogura; T Takatori; T Tsuruo
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

Review 3.  Molecular mechanisms of drug resistance.

Authors:  J D Hayes; C R Wolf
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

4.  Quantitative analysis of human multidrug resistance 1 (MDR1) gene expression by nonisotopic competitive reverse transcriptase polymerase chain reaction assay.

Authors:  H Kobayashi; Y Takemura; H Miyachi; M Kawabata; S Mori; Y Kawai; K Furihata; S Sekiguchi; K Watanabe
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

5.  Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance.

Authors:  G H Mickisch; G T Merlino; H Galski; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

6.  Reconstitution of purified P-glycoprotein into liposomes.

Authors:  M Naito; T Tsuruo
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Current status and future directions of research on multidrug resistance. The impact of contemporary biotechnology.

Authors:  G H Mickisch
Journal:  Urol Res       Date:  1993-03

8.  Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.

Authors:  M Kourti; N Vavatsi; N Gombakis; V Sidi; G Tzimagiorgis; T Papageorgiou; D Koliouskas; F Athanassiadou
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

9.  Expression of verapamil hypersensitivity in multidrug-resistant cells grown as multicellular spheroids.

Authors:  M Anderson; J R Warr
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

10.  Reversal of multidrug resistance by an immunosuppressive agent FK-506.

Authors:  M Naito; T Oh-hara; A Yamazaki; T Danki; T Tsuruo
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.